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Anterior cruciate ligament remnant tissue
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predicts higher healing potential
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Abstract
Background: No study has examined the possible factors associated with different characteristics of stem-like cells
derived from anterior cruciate ligament (ACL) remnants. And the purpose of the study is to elucidate whether
demographic factors are associated with healing potential of stem-like cells derived from the ACL remnants tissue.
Methods: Thirty-six ACL remnants were harvested from patients who received primary arthroscopic ACL reconstruction.
Interval from injury to surgery, age, sex, and combined meniscal or chondral injuries were analyzed. Cells were isolated
from remnant tissues and their healing potential was evaluated by: 1) characterization of surface markers (CD34, CD44,
CD45, CD146, CD29, and Stro-1), 2) cell expansion, 3) osteogenic differentiation, and 4) endothelial differentiation. Finally,
using multivariable logistic regression to evaluate the relation between demographic factors and healing potential
parameters. Adjusted odds ratios (OR) were calculated, and the significant difference was set at p < 0.05.
Results: ACL remnant tissue harvested less than 90 days after injury predicted higher fractions of stem-like
cells [CD34+ (OR = 6.043, p = 0.025), CD44 + (OR = 8.440, p = 0.011), CD45+ (OR = 16.144, p = 0.015), and CD146+
(OR = 9.246, p = 0.015)] and higher expansion potential (passage 3: OR = 9.755, p = 0.034; passage 10: OR = 33.245,
p = 0.003). Regarding osteogenic differentiation, higher gene expression of Osteocalcin (OR = 22.579, p = 0.009),
Alkaline phosphatase (OR = 6.527, p = 0.022), and Runt-related transcription factor 2 (OR = 5.247, p = 0.047) can also
be predicted. Younger age predicted higher CD34+ levels (20≤ age <30 years, OR = 2.020, p = 0.027) and higher
expansion potential at passage 10 (10≤ age <20 years, OR = 25.141, p = 0.026). There was no significant relation found
between meniscal or chondral injuries and ACL healing potential.
Conclusion: Our results indicated that the ACL remnant tissue harvested within 3-months after injury yields higher
healing potential, suggesting early surgical intervention may achieve better clinical results.
Keywords: Anterior cruciate ligament, Surgical timing, Multivariate logistic regression
Background
The anterior cruciate ligament (ACL) is often injured,
which predisposes the knee to subsequent injuries or
early onset of osteoarthritis (OA). Although ruptured
ACLs can be reconstructed, good results are not guaran-
teed, because of graft failure and recurrent instability, as
reported 0.7–10 % of patients [1, 2]. Therefore, in
addition to enhancing surgical techniques, intrinsic heal-
ing potential of the ACL should not be overlooked [3].
A tibial stump connecting [4] is often observed in
acute or sub-acute ACL injury during arthroscopy, indi-
cating that ACL fibers might have intrinsic healing
potential. A rich supply of CD 34+ stem/progenitor cells
was primarily found in blood vessels [5–8], and its heal-
ing potential was reinforced by several publications con-
secutively [9–12]. Since Matsumoto et al. reported that
CD34+ cells derived from human ACL ruptured tissue
exhibited higher proliferation and multi-lineage differen-
tiation potential [10], successive studies supported that
these cells or the ruptured tissue may contribute to the* Correspondence: matsun@m4.dion.ne.jp
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tendon-bone healing as well as to the reduction of tun-
nel enlargement [13–15].
However, controversies exist [16] on these results
because a superior clinical outcome cannot be assured
by the remnant preserving techniques compared to
those obtained with standard ACL reconstruction tech-
niques [17, 18]. We believe that some other factors
might be involved in the healing potential.
Therefore, the purpose of this study was to identify
whether demographic factors such as interval between
injury and surgery, age, sex, and combined meniscal or
chondral injuries were associated with characteristics
of ACL remnant-derived stem-like cells in the healing
potential of reconstructed ACL. The hypothesis was
that one or more factors would be associated with the
characterization, proliferation, and multi-lineage dif-
ferentiation potential of ACL remnant-derived stem-
like cells.
Methods
The Institutional Review Board of Kobe University
approved this study. Written informed consent was
obtained from all the subjects recruited in the
present study.
Subjects
Patients who had undergone primary arthroscopic ACL
reconstruction and those younger than 50 years were
included. ACL remnants from ACL revision surgery or
combined injury involving medial/lateral collateral
ligament or posterior cruciate ligament were excluded
from the study. Thirty-six ACL remnant tissues were
harvested by an arthroscopic surgeon with more than
10 years’ experience in arthroscopy. The interval be-
tween injury and surgery, age at injury, sex, and com-
bined meniscal or chondral injuries were selected as risk
factors. The interval between injury and surgery was cat-
egorized as < 90 days and ≥ 90 days. Age was categorized
as the 10′ group (10 ≤ age <20 years), the 20′ group
(20 ≤ age <30 years), and over 30′ group (≥30 years).
Cell isolation
The ACL remnant tissues were harvested from the
rupture site of 1.0 cm3 in size, preserved in the sterile
saline solution on ice, minced into 1–2 mm small parti-
cles, washed by phosphate-buffered saline (PBS) three
times, and then digested with 0.4 % collagenase type II
(0.4 % w/v; Worthington Biochemical Corporation,
Lakewood, New Jersey) for two hours in a 37 °C 5 %
CO2 incubator. The suspension was washed with PBS
and centrifuged at 1500 rpm for 10 min, and the super-
natant was discarded; the cells were suspended in PBS,
and then filtered through a 70-μM nylon cell strainer
(Becton Dickinson [BD], Franklin Lakes, New Jersey).
Later, the cells were washed with PBS twice, cultured in
standard Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 10 % fetal bovine serum (FBS) and
100 U/mL penicillin/streptomycin (Sigma-Aldrich) at a
density of 1 × 105 in 75 cm2 collagen-coated flask, then
incubated in 37 °C 5 % CO2 incubator. The medium was
changed every 3 days, and passaged the cells when they
reached 70–80 % confluent.
ACL remnant tissue-derived cell characterization
Flow cytometry assays were performed to characterize
ACL-derived cells. The in vitro-isolated cells were
washed three times with 0.5 % bovine serum albumin-
PBS for 5 min to prepare single-cell suspensions with
density of 1 × 106 cells/mL and perform the assay.
Fluorescein isothiocyanate-labeled primary antibody
was diluted in mouse serum at a ratio of 1:10 (Sigma-
Aldrich) and was incubated with cells for 30 min on
ice. Isotype control was defined as nonspecific mouse
IgG substituting for the primary antibody. Facial Action
Coding System (FACS) was performed by FACS Calibur
(BD Bioscience Pharmingen) and analyzed by CellQuest
(BD Pharmingen) software. The expression of cluster of
differentiation markers CD34/PE, CD146/FITC, CD45/
allophycocyanin (APC), CD44/FITC, CD29/PE, and
Stro-1/Alexa Fluor647 (BD Bioscience Pharmingen, San
Diego, California) were evaluated in this study.
Expansion potential assay
The expansion potential was calculated by population
doublings (PDs). Cells were cultured in 75 cm2 collagen-
coated flasks, and passaged every 7 days at the cell dens-
ity of 1.0 × 105/flask. The number of PDs of each passage




In line with a previously reported osteogenic differenti-
ation assessment [19, 20], a density of 1.0 × 105/well, four
replicated ACL-derived cells were treated with an
osteogenic medium, known as the α-minimum essential
medium (Invitrogen, Carlsbad, California) supplemented
with 10 % FBS, 100 U/mL penicillin/streptomycin solution
(Sigma-Aldrich), 0.1 mM dexamethasone (Sigma-Aldrich),
50 mM ascorbate-2-phosphate (Sigma-Aldrich), and
10 mM β-glycerophosphate (Sigma-Aldrich). To assess
the osteogenesis, the cells were fixed in 1 mL of ice-cold
70 % ethanol for 1 h at 4 °C and incubated with alkaline
phosphatase (ALP) dye (Fig. 1a) for 14 days. The same
procedure was performed after 21 days with alizarin red S
dye (Fig. 1b). Total RNA was isolated from cells on day 21
to analyze expression of Osteocalcin (F:TGTGAGCTC
AATCCGGACTGT; R: CCGATAGGCCTCCTGAAAGC),
Alkaline phosphatase (ALP) (F: ATGGGATGGGTGTCTC
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CACA; R: CCACGAAGGGGAACTTGTC), and Runt-
related transcription factor 2 (Runx2) (F: CCAGATGG
GACTGTGGTTACTG; R: TTCCGGAGCTCAGCAG
AATAA) using quantitative reverse transcription-real-
time polymerase chain reaction (qRT-PCR).
Endothelial differentiation
A density of 1.0 × 104/well, 4 replicates cells were
cultured in an endothelial growth medium-2 (EGM-2)
bullet kit (endothelial cell basic medium, hydrocortisone,
fibroblast growth factor-basic, vascular endothelial
growth factor, recombinant human long R3 insulin-like
growth factor-1 (R3-IGF-1), ascorbic acid, epidermal
growth factor (EGF), Gentamicin (GA; Amphotericin-B)-
1000, and heparin) supplemented with 10 % FBS, and
incubated at 37 °C in 5 % CO2 for 1 week.
To determine the cellular ability to uptake 1,1′-
dioctadecyl-3,3,3′,3′ -tetramethylindocarbocyanine (DiI)-
labeled acetylated low-density lipoprotein (acLDL)
(Biomedical Technologies, Staughton, Massachusetts)
and binding potential to Ulex europaeus lectin (Molecular
Probes, Eugene, Oregon), the cells were first incubated
with DiIacLDL (10 mg/mL) at 37 °C for 4 h, and then
fixed with 1 % paraformaldehyde for 10 min. Subse-
quently, cells were continuously incubated with FITC–
Ulex europaeus lectin (10 mg/mL) for 1 h. The slides were
Fig. 1 The figure showed ALP staining (a), Alizarin red S staining (b), fluorescence microscopic view of ACL remnant derived cells' Dil-Labeled
acLDL uptake and binding to Ulex Europaeus Lectin (c), and endothelial tubular formation (d) of the ACL-derived cells
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mounted by 4′,6-diamidino-2-phenylindole (DAPI) mount-
ing medium and viewed using an inverted fluorescence
microscope (Fig. 1c).
Further, endothelial tubular formation was studied in
Matrigel cultures. Briefly, 1.0 × 104 cells cultured in
endothelial basal medium-2 (EBM-2) were seeded onto
48-well plates coated with Matrigel (BD Biosciences, San
Jose, California). After 48 h cultured at 37 °C, the total
tube length was calculated from 3 randomly selected
low-power fields under a microscope (Fig. 1d).
Total RNA was harvested on day 7 from the cells in
monolayer culture–maintained endothelial cell culture
EGM-2. Expressions of endothelial VE-cadherin (VE-cad,
F: GGGAGACCACGCCTCTGTC; R: ACTGAACCT
GACCGTAGAGGAGGCCCTGGGCATCTC) and cluster
of differentiation 31(CD31) (F: GGTTCTGAGGGTG
AAGGTGA; R: TTGCAGCACAATGTCCTCTC) were
analyzed using qRT-PCR.
RNA extraction and quantitative reverse
transcription-real-time polymerase chain reaction
For qRT-PCR, total RNA was extracted from cells using
TRIzol reagent (Invitrogen) and an RNeasy mini kit
(Qiagen, Hilden, Germany) with on-column DNase diges-
tion. Later, RNA was reversed-transcribed to complemen-
tary deoxyribonucleic acid (cDNA) using the RevertAid
First Strand cDNA Synthesis Kit (Applied Biosystems,
Foster City, California). The cDNA of each sample was
amplified in a 20-μL PCR reaction mixture containing
SYBR Green Master Mix reagent (Applied Biosystems,
Tokyo, Japan) on the ABI Prism 7500 Sequence Detection
System (Applied Biosystems). Housekeeping Glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) (F: ATGGG
GAAGGTGAAGGTCG; R: GGGGTCATTGATGGCAA
CAATA) was used as calibrator, and sequences of other
primers for gene were obtained, as described previously.
The following cycling conditions were applied: denatur-
ation at 95 °C for 10 min, 40 cycles at 95 °C for 15 s, opti-
mal annealing temperature for 20 s, 72 °C for 30 s, and
60 °C to 95 °C with a heating rate of 0.5 °C/s. The relative
expression level of gene of interest was normalized to
GAPDH and was calculated according to the 2-ΔΔCT for-
mulas. For control, the cells were cultured with growth
medium.
Statistical analysis
Descriptive statistical analysis was performed for
demographic factors. The data were expressed as
mean ± standard error.
Predictor variables analyzed in the study were tested
as follows: the interval between injury and surgery
(≥90 days category was used as a reference), sex (male
sex was used as reference), age at injury (>30′ group was
used as reference), meniscal injury, chondral injury, and
combined meniscal or chondral injuries (no meniscal or
chondral injuries group was used as reference). Since the
number of chondral injury was too small to reach the
efficacy, the the combined meniscal or chondral injuries
was evaluated.
The characteristics of ACL-derived cells (CD34+,
CD44+, CD45+, CD146+, CD29+, and Stro-1+), expan-
sion potential (passage 3 and passage 10), osteogenic dif-
ferentiation (ALP activity, mRNA gene expression of
osteocalcin, ALP, and Runx2), and endothelial differenti-
ation (tube length, mRNA gene expression of VE-cad,
and CD31) were tested using multivariate logistic regres-
sion for binary outcomes. Since all the original data were
presented linearly, the median of each parameter was
calculated, and data were categorized into a high group
(above the median) and low group (below the median)
[21]. Adjusted odds ratios (ORs) and 95 % confidence in-
tervals (CIs) were calculated for each predictor variable.
Results were considered statistically significant when the
null value (1.00) was absent from the CI or P < 0.05.
SPSS 21.0 software (SPSS, Inc., Chicago, IL, USA) was
applied for the statistical analysis.
Results
Demographic characteristics
Sample characteristics are presented in Table 1. A total of
36 patients were recruited into this study. Eighteen patients
underwent surgery less than 90 days after the injury (mean,
48.9 ± 21.1 days), whereas 18 patients underwent surgery
later than 90 days (mean, 182.4 ± 91.0 days). The age range
of the subjects was from 14 to 46 (mean, 24.50 ± 7.97 years).
In all, 12, 13, and 11 subjects were included into the 10′,
20′, and >30’s group, respectively. Seventeen men and
nineteen women were included. There were 18 cases of
meniscal injury and 3 cases of chondral injury reported
during the surgery, one patient was reported to have both
meniscal and cartilage injury. The relation was evaluated
as meniscal injury, chondral injury, and combined menis-
cal and chondral injury.
Table 1 Demographic characteristics
Sex (male:female) 17:19
Age, mean ± SD, year
10≤ age < 20, n = 12 16.58 ± 1.68
20≤ age < 30, n = 13 23.71 ± 2.78
≥ 30, n = 11 35.10 ± 4.79
Interval from injury to surgery, day
< 90 days, n = 18 48.9 ± 21.1
≥ 90 days, n = 18 182.4 ± 91.0
Meniscal injury, case 18
Chondrl injury, case 3
Meniscus injury or cartilage degeneration, case 20
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Table 2 Multivariate association between factors in the CD34+, CD 44+, CD 45+, CD 146+, CD29+, and Stro-1+ (*p < 0.05)
CD34+ CD44+ CD45+ CD146+ CD29+ Stro-1+
p OR 95 % CI p OR 95 % CI p OR 95 % CI p OR 95 % CI p OR 95 % CI p OR 95 % CI
Interval from injury to
surgeryb, < 90 days
0.025* 6.043 1.259–28.995 0.011* 8.440 1.615–44.111 0.015* 16.144 1.701–153.212 0.015* 9.246 1.541–55.461 0.369 1.982 0.446–8.819 0.059 4.559 0.944–22.020
10 ≤ age <20 year-oldc 0.957 1.056 0.144–7.755 0.996 0.994 0.124–7.985 0.773 1.370 0.161–11.643 0.416 0.438 0.060–3.198 0.960 1.048 0.167–6.572 0.112 6.244 0.679–40.503
20 ≤ age <30 year-oldc 0.027* 2.020 1.413–26.512 0.795 1.370 0.127–14.775 0.593 1.954 0.189–20.215 0.178 0.176 0.016–1.888 0.593 0.569 0.071–4.575 0.577 1.919 0.194–18.972
Sexa Female 0.683 0.692 0.118–4.057 0.593 0.604 0.097–3.780 0.092 7.535 0.717–79.179 0.139 4.148 0.629–27.374 0.218 0.368 0.075–1.809 0.843 1.194 0.207–6.897
Meniscal injuryd 0.626 0.716 0.187–2.744 0.409 0.563 0.143–2.206 0.069 0.269 0.066–1.106 0.409 0.563 0.143–2.206 0.616 0.711 0.188–2.691 0.406 0.566 0.148–2.168
Chondral injuryd 0.433 2.714 0.223–32.992 0.327 3.500 0.286–42.769 0.761 0.679 0.056–8.248 0.327 3.500 0.286–42.769 0.554 2.125 0.175–25.775 0.688 0.600 0.049–7.283
Combined meniscal
or chondral injuriesd
0.549 0.667 0.177–2.513 0.593 0.692 0.180–2.668 0.117 0.333 0.084–1.318 0.593 0.692 0.180–2.668 0.503 0.636 0.169–2.391 0.549 0.667 0.177–2.513
aUse “male” category as reference
bUse “interval more than 90 days” category as reference
cUse “age more than 30-year old” category as reference













Predictors of risk factor
Logistic regression results for characterization of ACL-
derived cells, expansion potential, and differentiation
potential of osteogenesis and endotheliogenesis are pre-
sented in Tables 2, 3, 4, and 5.
Interval between injury and surgery
The ACL remnant tissue harvested within 90 days after
injury predicted higher cell fractions of CD34+, CD44+,
CD45+, and CD146+ (Table 2); higher expansion potential
at passage 3 and passage 10 (Table 3); and higher potential
of osteogenic differentiation in terms of Osteocalcin gene
expression, ALP levels, and Runx2 (Table 4).
However, there were no significant differences in the
osteogenic differentiation-ALP activity (p = 0.263), or
endothelial differentiation (Tables 4 and 5).
Age
In the characterization of ACL-derived cells, younger
age predicted higher CD34+ levels (Table 2) and higher
expansion potential at passage 10 (Table 3).
However, no such correlation was found in stem-like
cell fraction, such as CD44+, CD45+, CD146+, CD29+,
and Stro-1+ expression (Table 2). In addition, there were
no significant differences in osteogenic differentiation or
endothelial differentiation (Tables 4 and 5).
Sex
Female sex was associated with higher ALP activity
(Table 4), that attributed to osteogenic differentiation.
However, regarding the characterization of ACL-
derived cells, there were no significant differences in
cell expansion potential or endothelia differentiation
potential between male and female participant samples
(Tables 2 and 5).
Combined meniscal and cartilage injuries
No significant differences were detected in the charac-
terization of ACL-derived cells, ALP activity, cell expan-
sion potential or endothelia differentiation potential in
the patients who had combined meniscal or chondral
injuries (Tables 2-5).
Table 3 Multivariate association in expansion potential (*p < 0.05)
Passage 3 Passage 10
p OR 95 % CI p OR 95 % CI
Interval from injury to surgeryb, < 90 days 0.034* 9.755 1.187–80.186 0.003* 33.245 3.245–342.631
10 ≤ age <20 year-oldc 0.210 4.939 0.407–59.879 0.026* 25.141 1.484–426.057
20 ≤ age <30 year-oldc 0.521 2.250 0.189–26.831 0.339 3.528 0.267–46.676
Sexa Female 0.576 1.794 0.232–13.909 0.230 3.156 0.483–20.619
Menical injuryd 0.632 1.400 0.354–5.542 0.406 1.768 0.461–6.775
Chondral injuryd 0.837 1.300 0.107–15.836 0.492 0.417 0.034–5.057
Combined meniscal or chondral injuriesd 0.593 1.444 0.375–5.566 0.334 1.929 0.509–7.311
aUse “male” category as reference
bUse “interval more than 90 days” category as reference
cUse “age more than 30-year old” category as reference
dUse “no meniscal or chondral injuries” category as reference
Table 4 Multivariate association in osteogenic differentiation (*p < 0.05)
ALP activity Osteocalcin mRNA ALP mRNA Runx2 mRNA
p OR 95 % CI p OR 95 % CI p OR 95 % CI p OR 95 % CI
Interval from injury to
surgeryb, < 90 days
0.263 2.416 0.515–11.337 0.009* 20.579 2.119–199.882 0.022* 6.527 1.308–32.557 0.047* 5.247 1.023–26.922
10 ≤ age <20 year-oldc 0.895 0.884 0.142–5.491 0.384 2.683 0.290–24.782 0.962 0.954 0.141–6.481 0.592 0.600 0.092–3.895
20 ≤ age <30 year-oldc 0.240 0.277 0.033–2.356 0.909 1.155 0.097–13.787 0.742 1.420 0.176–11.451 0.480 0.463 0.055–3.924
Sexa Female 0.030* 12.831 1.279–128.746 0.850 0.831 0.123–5.606 0.885 1.131 0.212–6.041 0.550 0.601 0.113–3.191
Meniscal injuryd 0.218 2.400 0.596–9.670 0.198 2.600 0.606–11.152 0.360 1.920 0.475–7.766 0.803 1.200 0.287–5.021
Chondral injuryd 0.000 0.000 0.000–0.000 1.000 1.000 0.081–12.270 0.000 0.000 0.000–0.000 0.913 1.150 0.093–14.188
Combined meniscal
or chondral injuriesd
0.402 1.800 0.455–7.127 0.346 2.000 0.473–8.462 0.588 1.467 0.367–5.858 0.519 1.615 0.376–6.940
aUse “male” category as reference
bUse “interval more than 90 days” category as reference
cUse “age more than 30-year old” category as reference
dUse “no meniscal or chondral injuries” category as reference
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Discussion
The findings of this study supported the primary hypothesis
that the ACL remnant tissues collected within 90 days after
injury had higher fractions of CD34+, CD44+, CD45+, and
CD146+ cells in the tissue, higher cell expansion potential,
and higher osteogenic differentiation potential. These re-
sults suggested that a higher healing potential in the ACL
remnant tissue could be predicted in the short interval be-
tween injury to surgery, and in younger patients.
First of all, surgical timing of ACL reconstruction has
widely been discussed in the literatures in terms of risk
of meniscal or cartilage lesion [22–26], postoperative
range of motion recovery [27–29], incidence of arthrofi-
brosis [30], and return of quadriceps muscle strength
[31]. Besides mechanical stability, the success of ACL
reconstruction may also depend on biological graft heal-
ing. One study suggested that the ideal time from ACL
injury to operation is between 1 and 6 months [32, 33]
because of the reduced risk of meniscal or cartilage
lesion occurrence [13, 14], better stability, or clinical
evaluation [28], and the ability to return to sports and
occupations [34, 35]. Meanwhile, Lee et al found there
were significantly less mesenchymal stromal cells in
the ACL remnant tissue harvested after 6 months of
injury [36]. Those results were consistent to our study
findings, proving that surgical timing is a critical fac-
tor to be considered during medical consultation.
Early surgical intervention may preserve the healing
potentiality of the ACL remnant tissue, thus predict-
ing a better clinical outcome.
Second, age is another predictor of ACL remnant heal-
ing potential. One study found that CD34+ cells were
more prevalent in adolescents’ ACL remnants; the num-
ber of these cells decreased with age [37]. Our study
further proved that younger age was associated with a
higher percentage of CD34+ cells in the ACL remnant
tissue and higher cell expansion potential. In a recently
published cohort study, Nakano et al. [38] proved that
ACL-derived cells of younger patients enhanced early
bone-tendon healing in an immune-deficient rat model
of ACL reconstruction in a rat model.
However, other studies argued that the remnant-
preserved augmentation ACL reconstruction did not
significantly improve knee stability or clinical scores
[39–41]. The conflicts between clinical outcome and
basic study results indicated that long-term follow-up,
technique improvement, or advanced postoperative
function measurements are required to fairly evaluate
the remnant preservation ACL reconstruction.
It has been frequently noticed that the delayed ACL
reconstruction increased the risks of secondary meniscal
and chondral injury [42], and it has been recently
reported that delayed ACL reconstruction increased the
risks of secondary meniscal and chondral injuries in this
population of pediatric patients [33]. Our study also
looked into the correlation between the meniscal and
articular cartilage injuries and ACL healing potential,
but failed to detect the significant difference. Since the
risk of meniscal and cartilage injuries was increased with
the time after ACL injury, meniscal and cartilage injuries
might not be an independent factor to evaluate as a pre-
dictor. Further, knee arthrofibrosis is one of the most
serious complications that can result from ligament
surgery with a reported incidence following ACL recon-
struction ranging from 4 to 35 %, and patients with
reconstruction within the first two weeks of injury have
a significant increase in arthrofibrosis, compared to
those surgically treated after three weeks from injury
[30]. The early surgical timing may also benefit the pa-
tients of less incidence of arthrofibrosis.
This study has several limitations. Some other factors,
not detected in this study, may significantly be related to
ACL remnant tissue features. The decision of when to
undergo ACL reconstruction is likely multifactorial and
other factors such as pre-operative status of the knee,
family support, school education, work obligation, and
Table 5 Multivariate association in endothelial differentiation (*p < 0.05)
Tube length VE-cadherin mRNA CD31 mRNA
p OR 95 % CI p OR 95 % CI p OR 95 % CI
Interval from injury to surgeryb, < 90 days 0.495 2.409 0.193–30.046 0.836 0.824 0.132–5.156 0.073 7.337 0.832–64.742
10 ≤ age <20 year-oldc 0.430 2.659 0.234–30.160 0.317 3.118 0.337–28.884 0.504 0.438 0.039–4.924
20 ≤ age <30 year-oldc 0.966 0.690 0.064–7.429 0.781 1.421 0.120–16.863 0.620 0.494 0.031–8.001
Sexa Female 0.190 4.987 0.452–55.045 0.265 0.335 0.049–2.293 0.458 2.245 0.265–19.001
Meniscal injuryd 0.848 0.857 0.178–4.126 0.198 2.600 0.606–11.152 0.862 1.125 0.298–4.241
Chondral injuryd 0.547 0.458 0.036–6.789 0.000 0.000 0.000–0.000 0.619 0.531 0.044–6.444
Combined meniscal or condral injuriesd 0.966 1.010 0.214–4.674 0.346 2.000 0.473–8.462 0.765 0.818 0.219–3.056
aUse “male” category as reference
bUse “interval more than 90 days” category as reference
cUse “age more than 30-year old” category as reference
dUse “no meniscal or chondral injuries” category as reference
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mental preparation should also be considered. Further,
smoking habits and activity levels were identified as
adverse factors affecting ACL reconstruction outcomes.
Those factors may modify the intra-articular microenvir-
onment and interact with ACL-derived cells. Another
limitation was that a higher percentage of CD34+ does
not always correlate with higher differentiation potential
of osteogenesis or endothelial, suggesting that CD34+
cells do not switch to mesenchymal cell population with
passage, and this problem needs to be addressed in fu-
ture studies by increasing the sample size.
Conclusion
In this study, we proved that a shorter interval from injury
to surgery resulted in not only a higher fraction of CD34+,
CD44+, CD45+, and CD146+ cells in the remnant tissue,
but also increased expansion potential and osteogenic dif-
ferentiation. In addition, we proved that younger age pre-
dicted higher CD34+ fractions and higher cell expansion
potential. In conclusion, in cases of remnant-preserved
ACL reconstruction or ACL reconstruction involving rup-
tured tissue, early surgical intervention and younger age
may predict better healing potential.
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EGM-2: endothelial growth medium-2; FACS: Facial Action Coding System;
FBS: fetal bovine serum; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase;
OA: osteoarthritis; OR: odds ratios; PBS: phosphate-buffered saline;
PDs: population doublings; qRT-PCR: quantitative reverse transcription-real-time
polymerase chain reaction; R3-IGF-1: R3 insulin-like growth factor-1;
Runx2: Runt-related transcription factor 2; VE-cad: VE-cadherin.
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